Novartis on how to lower the cost of quality heart health care in Africa

In Africa, the burden of cardiovascular diseases continues to be a major concern, with millions of people facing the risk of heart-related illnesses every year. According to the World Health Organization, 17.9 million people die from cardiovascular diseases annually, representing 31 percent of global deaths. The high cost of quality health care has been a significant barrier to effective treatment and prevention measures. To address this pressing issue, public-private partnerships have emerged as a key strategy to transform the landscape of heart healthcare in Africa. Racey Muchilwa, Country President & Head of Novartis Sub Saharan Africa, has been at the forefront of efforts to enhance access to affordable and effective heart healthcare solutions in the region. Muchilwa highlighted the importance of collaboration between public and private sectors to strengthen healthcare systems and broaden patient access to life-saving medication and diagnostic tools. Novartis has taken concrete steps to support these goals by partnering with various organizations and investing in training programs for healthcare professionals. Through initiatives like the partnership with the University of Nairobi Enterprise and Services, Novartis has sponsored the training of over 115 doctors in cardiac diagnosis and echocardiogram, with a focus on rural areas where access to modern medical equipment is limited. Additionally, the company has donated ultrasound devices to equip healthcare providers in underserved communities, enabling them to diagnose and treat heart conditions more effectively. By leveraging innovative partnerships and prioritizing preventive care, Novartis is driving positive change in the fight against cardiovascular diseases in Africa. The road to affordable and quality heart healthcare may require a multifaceted approach, including policy interventions to promote healthy lifestyles, education on proper nutrition, and increased access to screening and diagnostic tools in rural areas. Novartis's commitment to improving heart healthcare in Africa serves as a beacon of hope for millions of individuals at risk of cardiovascular diseases, paving the way for a healthier and more resilient future for the continent.